ACADIA Pharmaceuticals, Inc. (NASDAQ:ACAD)
The Company is a biopharmaceutical company focused on the discovery, development, and commercialization of small molecule drugs for the treatment of central nervous system disorders.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
Recs
Pure spec
Recs
good time for pharmsss.
Recs
Low market cap related to potential for drug candidates. Requires patience - buy on dips
Recs
intimately familar with company
Recs
This company has great protential. Plus if you consider the list of drugs that plan to come out there could be real profit here!
Recs
Great pipeline of drugs comming out within the next couple years.
Recs
Small-cap biotech should perform through mid-year 2007
Recs
potential block busters in pipeline
Recs
It's oversold
Recs
Picked by dockofthebay
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 21 - 30 of 30 : « Previous 1 2